Published in PLoS One on February 17, 2012
Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects. Neurotoxicology (2012) 0.89
α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease. Toxicol Sci (2014) 0.88
Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features. Int J Environ Res Public Health (2015) 0.86
A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease. Hum Mol Genet (2014) 0.84
Considerations on manganese (Mn) treatments for in vitro studies. Neurotoxicology (2014) 0.84
Inhibition of Excessive Monoamine Oxidase A/B Activity Protects Against Stress-induced Neuronal Death in Huntington Disease. Mol Neurobiol (2014) 0.82
Subacute manganese exposure in rats is a neurochemical model of early manganese toxicity. Neurotoxicology (2014) 0.81
Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status. Metallomics (2015) 0.80
BDNF and Huntingtin protein modifications by manganese: implications for striatal medium spiny neuron pathology in manganese neurotoxicity. J Neurochem (2014) 0.79
Optimising Golgi-Cox staining for use with perfusion-fixed brain tissue validated in the zQ175 mouse model of Huntington's disease. J Neurosci Methods (2015) 0.78
Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model. Biochim Biophys Acta (2017) 0.77
Loss of Cdk5 function in the nucleus accumbens decreases wheel running and may mediate age-related declines in voluntary physical activity. J Physiol (2016) 0.75
Dendritic organization in the neurons of the visual and motor cortices of the cat. J Anat (1953) 12.20
Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol (1985) 7.93
The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet (1993) 5.82
Influence of dendritic structure on firing pattern in model neocortical neurons. Nature (1996) 5.59
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci (2006) 4.98
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet (2003) 4.07
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A (2004) 3.73
Manganism and idiopathic parkinsonism: similarities and differences. Neurology (1994) 3.34
Propagation of action potentials in dendrites depends on dendritic morphology. J Neurophysiol (2001) 3.05
Inactivation of the mouse Huntington's disease gene homolog Hdh. Science (1995) 2.96
The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am J Hum Genet (1997) 2.84
Dendritic integration of excitatory synaptic input. Nat Rev Neurosci (2000) 2.83
Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J Neurosci (1997) 2.39
Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice. Neuron (2010) 2.36
Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models. Neurobiol Dis (2009) 2.29
Manganese-induced parkinsonism and Parkinson's disease. Ann N Y Acad Sci (2004) 2.25
Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science (1985) 2.23
Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc Natl Acad Sci U S A (1998) 2.14
Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum Mol Genet (1993) 2.00
Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology (1999) 1.97
Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J Neurophysiol (2001) 1.91
Synaptic integration in an excitable dendritic tree. J Neurophysiol (1993) 1.86
Age-related dendritic and spine changes in corticocortically projecting neurons in macaque monkeys. Cereb Cortex (2003) 1.83
Manganese dosimetry: species differences and implications for neurotoxicity. Crit Rev Toxicol (2005) 1.83
Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J Neurosci (2005) 1.82
Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol (1988) 1.79
Role of manganese in neurodegenerative diseases. J Trace Elem Med Biol (2011) 1.73
Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice. Proc Natl Acad Sci U S A (2000) 1.66
Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology (1996) 1.60
Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp Neurol (2006) 1.59
Subthreshold dendritic signal processing and coincidence detection in dentate gyrus granule cells. J Neurosci (2007) 1.51
The integrative properties of spiny distal dendrites. Neuroscience (1992) 1.50
Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. Biochem Pharmacol (2003) 1.48
Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry. J Neurosci (1991) 1.45
Dopaminergic signaling and striatal neurodegeneration in Huntington's disease. J Neurosci (2007) 1.44
Timing and location of synaptic inputs determine modes of subthreshold integration in striatal medium spiny neurons. J Neurosci (2007) 1.40
Neurobehavioral evaluation of rhesus monkey infants fed cow's milk formula, soy formula, or soy formula with added manganese. Neurotoxicol Teratol (2005) 1.33
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol (2005) 1.32
Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism. J Neurochem (2008) 1.31
On the electrical function of dendritic spines. Trends Neurosci (2004) 1.30
Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease. J Neurochem (2006) 1.29
Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice. Eur J Neurosci (2004) 1.27
Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production. Exp Neurol (2001) 1.27
Manganese: brain transport and emerging research needs. Environ Health Perspect (2000) 1.25
Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol Appl Pharmacol (2009) 1.23
Interactive effects of stress and aging on structural plasticity in the prefrontal cortex. J Neurosci (2010) 1.18
In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ Health Perspect (2010) 1.16
Aging and sex influence the anatomy of the rat anterior cingulate cortex. Neurobiol Aging (2002) 1.13
Low cumulative manganese exposure affects striatal GABA but not dopamine. Neurotoxicology (2002) 1.13
Dysregulation of intracellular dopamine stores revealed in the R6/2 mouse striatum. J Neurochem (2009) 1.10
Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia. J Neurochem (2009) 1.06
Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration. J Alzheimers Dis (2006) 1.03
Basal Ganglia accumulation and motor assessment following manganese chloride exposure in the C57BL/6 mouse. Int J Toxicol (2006) 1.02
Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease. Neurobiol Dis (2011) 1.01
Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposure. J Neurochem (2009) 1.00
Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss. Cereb Cortex (2010) 0.99
Brain accumulation and toxicity of Mn(II) and Mn(III) exposures. Toxicol Sci (2006) 0.99
Age-related and laminar-specific dendritic changes in the medial frontal cortex of the rat. Brain Res (2002) 0.97
Dopamine and norepinephrine turnover in various regions of the rat brain after chronic manganese chloride administration. Toxicology (1982) 0.95
Alterations in brain dopamine and GABA following inorganic or organic manganese administration. Neurotoxicology (1982) 0.94
Extracerebellar role for Cerebellin1: modulation of dendritic spine density and synapses in striatal medium spiny neurons. J Comp Neurol (2010) 0.94
Basal ganglia neurotransmitter concentrations in rhesus monkeys following subchronic manganese sulfate inhalation. Am J Ind Med (2007) 0.93
Effects of chronic immobilization stress on anxiety-like behavior and basolateral amygdala morphology in Fmr1 knockout mice. Neuroscience (2011) 0.93
Altered manganese homeostasis and manganese toxicity in a Huntington's disease striatal cell model are not explained by defects in the iron transport system. Toxicol Sci (2010) 0.91
Effect of manganese on the concentration of amino acids in different regions of the rat brain. J Environ Sci Health B (1999) 0.91
Genetic and environmental factors in the pathogenesis of Huntington's disease. Neurogenetics (2004) 0.90
Modeling brain reserve: experience-dependent neuronal plasticity in healthy and Huntington's disease transgenic mice. Am J Geriatr Psychiatry (2009) 0.90
Manganese accumulation in striatum of mice exposed to toxic doses is dependent upon a functional dopamine transporter. Environ Toxicol Pharmacol (2005) 0.89
Influence of manganese on the release of neurotransmitters in rat striatum. Brain Res (2003) 0.89
Effects of manganese on extracellular levels of dopamine in rat striatum: an analysis in vivo by brain microdialysis. Neurochem Res (2005) 0.88
Manganese influences the levels of neurotransmitters in synapses in rat brain. Neuroscience (2002) 0.88
Effects of chronic manganese exposure on glutamatergic and GABAergic neurotransmitter markers in the nonhuman primate brain. Toxicol Sci (2009) 0.87
Novel high-throughput assay to assess cellular manganese levels in a striatal cell line model of Huntington's disease confirms a deficit in manganese accumulation. Neurotoxicology (2011) 0.87
Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease. Mov Disord (1999) 0.85
Impaired dopamine release and uptake in R6/1 Huntington's disease model mice. Neurosci Lett (2011) 0.85
Behavioral and neurotoxicological effects of subchronic manganese exposure in rats. Environ Toxicol Pharmacol (2005) 0.84
Brain regional manganese levels and monoamine metabolism in manganese-treated neonatal rats. Neurotoxicol Teratol (1989) 0.84
Differential effects of cholinergic lesions on dendritic spines in frontal cortex of young adult and aging rats. Brain Res (2003) 0.83
Different phenotypic expression in monozygotic twins with Huntington disease. Am J Med Genet A (2004) 0.80
Quantitative analysis of age-related dendritic changes in medium spiny I (MSI) striatal neurons of C57BL/6N mice. Neurobiol Aging (1990) 0.78
Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease. Acta Biochim Pol (2004) 0.77
Age-related changes in basal dendrite and dendritic spine of hippocampal pyramidal neurons (CA1) among SAMP1TA/Ngs--quantitative analysis by the rapid Golgi method. Mech Ageing Dev (1995) 0.76
Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature (2008) 3.68
ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell (2006) 3.39
Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci U S A (2005) 2.90
Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol Sci (2008) 2.49
Manganese neurotoxicity may underlie the association between early life iron deficiency and impaired spatial cognition in neonatal piglets. J Nutr (2013) 2.16
Glutamine-expanded ataxin-7 alters TFTC/STAGA recruitment and chromatin structure leading to photoreceptor dysfunction. PLoS Biol (2006) 2.12
Nutritional aspects of manganese homeostasis. Mol Aspects Med (2005) 2.03
Manganese neurotoxicity. Ann N Y Acad Sci (2004) 1.94
Role of manganese in neurodegenerative diseases. J Trace Elem Med Biol (2011) 1.73
Mefloquine neurotoxicity is mediated by non-receptor tyrosine kinase. Neurotoxicology (2011) 1.56
Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol Appl Pharmacol (2003) 1.55
Manganese transport in eukaryotes: the role of DMT1. Neurotoxicology (2008) 1.53
The inhibitory effect of manganese on acetylcholinesterase activity enhances oxidative stress and neuroinflammation in the rat brain. Toxicology (2011) 1.51
Developmental neuropathology of environmental agents. Annu Rev Pharmacol Toxicol (2004) 1.28
Oxidative stress in MeHg-induced neurotoxicity. Toxicol Appl Pharmacol (2011) 1.28
Anticholinesterase toxicity and oxidative stress. ScientificWorldJournal (2006) 1.27
Manganese neurotoxicity: a focus on the neonate. Pharmacol Ther (2006) 1.26
Speciation of manganese in cells and mitochondria: a search for the proximal cause of manganese neurotoxicity. Neurotoxicology (2006) 1.25
Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans. PLoS Genet (2010) 1.23
Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol Appl Pharmacol (2009) 1.23
Manganese accumulates in iron-deficient rat brain regions in a heterogeneous fashion and is associated with neurochemical alterations. Biol Trace Elem Res (2002) 1.23
Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation. J Neurochem (2009) 1.23
Interactions between excessive manganese exposures and dietary iron-deficiency in neurodegeneration. Environ Toxicol Pharmacol (2005) 1.22
Down-regulation of early ionotrophic glutamate receptor subunit developmental expression as a mechanism for observed plasticity deficits following gestational exposure to benzo(a)pyrene. Neurotoxicology (2007) 1.22
Manganese neurotoxicity and glutamate-GABA interaction. Neurochem Int (2003) 1.20
Glutathione modulation influences methyl mercury induced neurotoxicity in primary cell cultures of neurons and astrocytes. Neurotoxicology (2006) 1.20
Manganese induces oxidative impairment in cultured rat astrocytes. Toxicol Sci (2007) 1.20
Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders. Occup Environ Med (2012) 1.17
Mechanisms of methylmercury-induced neurotoxicity: evidence from experimental studies. Life Sci (2011) 1.16
In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ Health Perspect (2010) 1.16
Metallothionein in the central nervous system: Roles in protection, regeneration and cognition. Neurotoxicology (2008) 1.15
Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity. Exp Neurol (2007) 1.15
SyM-BBB: a microfluidic Blood Brain Barrier model. Lab Chip (2013) 1.12
ATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarization. Dev Cell (2011) 1.12
SMF-1, SMF-2 and SMF-3 DMT1 orthologues regulate and are regulated differentially by manganese levels in C. elegans. PLoS One (2009) 1.11
Iron deficient and manganese supplemented diets alter metals and transporters in the developing rat brain. Toxicol Sci (2006) 1.11
Roles of glutamine in neurotransmission. Neuron Glia Biol (2011) 1.11
Manganese exposure among smelting workers: blood manganese-iron ratio as a novel tool for manganese exposure assessment. Biomarkers (2009) 1.11
DMH1, a highly selective small molecule BMP inhibitor promotes neurogenesis of hiPSCs: comparison of PAX6 and SOX1 expression during neural induction. ACS Chem Neurosci (2012) 1.11
Globus pallidus: a target brain region for divalent metal accumulation associated with dietary iron deficiency. J Nutr Biochem (2004) 1.09
Manganese exposure and induced oxidative stress in the rat brain. Sci Total Environ (2004) 1.08
Manganese-induced cytotoxicity in dopamine-producing cells. Neurotoxicology (2004) 1.08
Prenatal methylmercury exposure hampers glutathione antioxidant system ontogenesis and causes long-lasting oxidative stress in the mouse brain. Toxicol Appl Pharmacol (2007) 1.07
Pathophysiology of manganese-associated neurotoxicity. Neurotoxicology (2011) 1.06
Role of astrocytes in brain function and disease. Toxicol Pathol (2010) 1.06
Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia. J Neurochem (2009) 1.06
DHCEO accumulation is a critical mediator of pathophysiology in a Smith-Lemli-Opitz syndrome model. Neurobiol Dis (2011) 1.05
A manganese-enhanced diet alters brain metals and transporters in the developing rat. Toxicol Sci (2006) 1.05
Methylmercury induces acute oxidative stress, altering Nrf2 protein level in primary microglial cells. Toxicol Sci (2010) 1.05
The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid regulation. Neurochem Int (2006) 1.05
Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease. Chem Rev (2009) 1.04
Estrogen and tamoxifen reverse manganese-induced glutamate transporter impairment in astrocytes. J Neurochem (2009) 1.04
Prenatal exposure to benzo(a)pyrene impairs later-life cortical neuronal function. Neurotoxicology (2008) 1.03
Determining the oxidation states of manganese in NT2 cells and cultured astrocytes. Neurobiol Aging (2005) 1.03
Methylmercury induces oxidative injury, alterations in permeability and glutamine transport in cultured astrocytes. Brain Res (2006) 1.03
Modulatory effect of glutathione status and antioxidants on methylmercury-induced free radical formation in primary cultures of cerebral astrocytes. Brain Res Mol Brain Res (2005) 1.03
Manganese Is Essential for Neuronal Health. Annu Rev Nutr (2015) 1.03
Measuring brain manganese and iron accumulation in rats following 14 weeks of low-dose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol Sci (2008) 1.02
The methylmercury-L-cysteine conjugate is a substrate for the L-type large neutral amino acid transporter. J Neurochem (2008) 1.02
Methylmercury-induced reactive oxygen species formation in neonatal cerebral astrocytic cultures is attenuated by antioxidants. Brain Res Mol Brain Res (2003) 1.01
Prenatal polycyclic aromatic hydrocarbon exposure leads to behavioral deficits and downregulation of receptor tyrosine kinase, MET. Toxicol Sci (2010) 1.00
Manganese causes differential regulation of glutamate transporter (GLAST) taurine transporter and metallothionein in cultured rat astrocytes. Neurotoxicology (2002) 1.00
Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposure. J Neurochem (2009) 1.00
Mitochondrial-dependent manganese neurotoxicity in rat primary astrocyte cultures. Brain Res (2008) 0.99
Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury. Neurochem Int (2012) 0.99
Increased manganese uptake by primary astrocyte cultures with altered iron status is mediated primarily by divalent metal transporter. Neurotoxicology (2005) 0.99
Manganese inhalation by rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity. Toxicol Sci (2007) 0.99
Estrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytes. Toxicol Sci (2009) 0.98
Manganese (Mn) and iron (Fe): interdependency of transport and regulation. Neurotox Res (2009) 0.98
Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist. Toxicol Appl Pharmacol (2009) 0.98
Modulation of cholinergic systems by manganese. Neurotoxicology (2007) 0.98
Methylmercury-induced alterations in astrocyte functions are attenuated by ebselen. Neurotoxicology (2011) 0.98
Measurement of isoprostanes as markers of oxidative stress in neuronal tissue. Curr Protoc Toxicol (2009) 0.97
Leaching of trace elements from biological tissue by formalin fixation. Biol Trace Elem Res (2007) 0.97
Mefloquine induces oxidative stress and neurodegeneration in primary rat cortical neurons. Neurotoxicology (2010) 0.96
GPR30 regulates glutamate transporter GLT-1 expression in rat primary astrocytes. J Biol Chem (2012) 0.96
Free radical formation in cerebral cortical astrocytes in culture induced by methylmercury. Brain Res Mol Brain Res (2004) 0.96
Retracted Polymorphic ventricular tachycardia and abnormal Ca2+ handling in very-long-chain acyl-CoA dehydrogenase null mice. Am J Physiol Heart Circ Physiol (2007) 0.96
Neonatal rat primary microglia: isolation, culturing, and selected applications. Curr Protoc Toxicol (2010) 0.95
Characterization of the effects of methylmercury on Caenorhabditis elegans. Toxicol Appl Pharmacol (2009) 0.94
The importance of glutamate, glycine, and gamma-aminobutyric acid transport and regulation in manganese, mercury and lead neurotoxicity. Toxicol Appl Pharmacol (2005) 0.94
A chronic iron-deficient/high-manganese diet in rodents results in increased brain oxidative stress and behavioral deficits in the morris water maze. Neurotox Res (2009) 0.93
Comparative study on the response of rat primary astrocytes and microglia to methylmercury toxicity. Glia (2011) 0.93
Transforming growth factor-α mediates estrogen-induced upregulation of glutamate transporter GLT-1 in rat primary astrocytes. Glia (2012) 0.92
Role of astrocytes in manganese mediated neurotoxicity. BMC Pharmacol Toxicol (2013) 0.92
Methylmercury toxicity and Nrf2-dependent detoxification in astrocytes. Toxicol Sci (2008) 0.92
Diphenyl diselenide, a simple organoselenium compound, decreases methylmercury-induced cerebral, hepatic and renal oxidative stress and mercury deposition in adult mice. Brain Res Bull (2008) 0.92
trans-10,cis-12-Conjugated linoleic acid instigates inflammation in human adipocytes compared with preadipocytes. J Biol Chem (2010) 0.92
Hormetic effect of methylmercury on Caenorhabditis elegans. Toxicol Appl Pharmacol (2010) 0.92
Changes in dietary iron exacerbate regional brain manganese accumulation as determined by magnetic resonance imaging. Toxicol Sci (2010) 0.92
Measurement of isoprostanes as markers of oxidative stress. Methods Mol Biol (2011) 0.91
Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity. Neurotoxicology (2011) 0.91
Altered manganese homeostasis and manganese toxicity in a Huntington's disease striatal cell model are not explained by defects in the iron transport system. Toxicol Sci (2010) 0.91
Lipid modifications of Sonic hedgehog ligand dictate cellular reception and signal response. PLoS One (2011) 0.91